Cargando…

Melatonergic signalling instructs transcriptional inhibition of IFNGR2 to lessen interleukin‐1β‐dependent inflammation

BACKGROUND: Immunotransmitters (e.g., neurotransmitters and neuromodulators) could orchestrate diverse immune responses; however, the elaborated mechanism by which melatonergic activation governs inflammation remains less defined. METHODS: Primary macrophages, various cell lines, and Pasteurella mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Yaoyao, Zhang, Qingzhuo, Ye, Yuyi, Wu, Xiaoyan, He, Fang, Peng, Yuanyi, Yin, Yulong, Ren, Wenkai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858632/ https://www.ncbi.nlm.nih.gov/pubmed/35184395 http://dx.doi.org/10.1002/ctm2.716

Ejemplares similares

Melatonergic drugs in development
por: Carocci, Alessia, et al.
Publicado: (2014)

Betaine Inhibits Interleukin-1β Production and Release: Potential Mechanisms
por: Xia, Yaoyao, et al.
Publicado: (2018)

Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic Insights
por: He, Fang, et al.
Publicado: (2021)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Melatonin and melatonergic drugs in sleep disorders
por: Kim, Hyung Ki, et al.
Publicado: (2022)

GABA transporter sustains IL-1β production in macrophages
por: Xia, Yaoyao, et al.
Publicado: (2021)

Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway
por: Anderson, George
Publicado: (2020)

circIFNGR2 regulating ankylosing spondylitis-associated inflammation through macrophage polarization
por: Song, Minkai, et al.
Publicado: (2023)

IFNGR1 single nucleotide polymorphisms in rheumatoid arthritis
por: Mattyasovszky, Stefan, et al.
Publicado: (2006)

Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders
por: Onaolapo, O.J., et al.
Publicado: (2020)

Assessment of Melatonergics in Prevention of Delirium: A Systematic Review and Meta-Analysis
por: Zhu, Yibing, et al.
Publicado: (2020)

Lessening Production
Publicado: (1874)

Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub
por: Anderson, George
Publicado: (2022)

Genetic Polymorphisms of IFNG and IFNGR1 with Latent Tuberculosis Infection
por: Wu, Shouquan, et al.
Publicado: (2019)

Acute toxicity and genotoxicity studies on new melatonergic antidepressant GW117
por: Gao, Mei, et al.
Publicado: (2023)

Association of IFNGR2 gene polymorphisms with pulmonary tuberculosis among the Vietnamese
por: Hijikata, Minako, et al.
Publicado: (2011)

Lessen uit 2020
por: Hageman, Alexia
Publicado: (2020)

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
por: Fornaro, Michele, et al.
Publicado: (2010)

The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
por: De Berardis, Domenico, et al.
Publicado: (2013)

N‐(Anilinoethyl)amide Melatonergic Ligands with Improved Water Solubility and Metabolic Stability
por: Ferlenghi, Francesca, et al.
Publicado: (2021)

Complementation of a pathogenic IFNGR2 misfolding mutation with modifiers of N-glycosylation
por: Vogt, Guillaume, et al.
Publicado: (2008)

Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection
por: Eshleman, Emily M., et al.
Publicado: (2017)

De lessen van 2020
por: Eskes, Anne, et al.
Publicado: (2020)

Assessment of melatonergics in prevention of delirium in critically ill patients: A protocol for systematic review and meta-analysis
por: Zhu, Yibing, et al.
Publicado: (2020)

Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma
por: Zhang, Xia, et al.
Publicado: (2023)

Association of Genetic Polymorphisms of IFNGR1 with the Risk of Pulmonary Tuberculosis in Zahedan, Southeast Iran
por: Naderi, Mohammad, et al.
Publicado: (2015)

IFNGR1 signaling is associated with adverse pregnancy outcomes during infection with malaria parasites
por: Niikura, Mamoru, et al.
Publicado: (2017)

Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNA
por: Zan, Jie, et al.
Publicado: (2021)

Association between IFNGR1 gene polymorphisms and tuberculosis susceptibility: A meta-analysis
por: Cheng, Liwei, et al.
Publicado: (2022)

New Grasspeas Lessen Risk of Paralysis
por: Greene, LA
Publicado: (2000)

To Shorten and Lessen the Pain of Natural Labor
por: Morris, John
Publicado: (1884)

Association of IFNGR1 and IFNG genetic polymorphisms with the risk for pulmonary tuberculosis in the Chinese Tibetan population
por: He, Shumei, et al.
Publicado: (2017)

Ligand-induced IFNGR1 down-regulation calibrates myeloid cell IFNγ responsiveness
por: Crisler, William J, et al.
Publicado: (2019)

Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression
por: Boiko, Dmytro I., et al.
Publicado: (2022)

Mechanisms that lessen benefits of β-secretase reduction in a mouse model of Alzheimer's disease
por: Devi, L, et al.
Publicado: (2013)

An Essay on Lessening Pain and Facilitating Difficult Parturition
Publicado: (1820)

Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD
por: Ashami, Kidist, et al.
Publicado: (2018)

Ironing Out the Details: How Iron Orchestrates Macrophage Polarization
por: Xia, Yaoyao, et al.
Publicado: (2021)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Howland, Robert H
Publicado: (2009)

Tumor Microenvironment and Metabolism: Role of the Mitochondrial Melatonergic Pathway in Determining Intercellular Interactions in a New Dynamic Homeostasis
por: Anderson, George
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lks9fv1d303mdhlnajgnq59m6s